These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8818649)
1. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Starr PA; Lim F; Grant FD; Trask L; Lang P; Yu L; Geller AI Gene Ther; 1996 Jul; 3(7):615-23. PubMed ID: 8818649 [TBL] [Abstract][Full Text] [Related]
2. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207 [TBL] [Abstract][Full Text] [Related]
3. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector. Warden MP; Weir JP Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330 [TBL] [Abstract][Full Text] [Related]
4. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors]. Yang T; Wang X; Yan Z; Hou Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234 [TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
6. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas. Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566 [TBL] [Abstract][Full Text] [Related]
7. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors. Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Ozuer A; Wechuck JB; Russell B; Wolfe D; Goins WF; Glorioso JC; Ataai MM Biotechnol Prog; 2002; 18(3):476-82. PubMed ID: 12052062 [TBL] [Abstract][Full Text] [Related]
9. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals. Berthomme H; Fournel S; Epstein AL Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275 [TBL] [Abstract][Full Text] [Related]
10. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide. Sun M; Lee J; Yu L; Geller AI Acta Virol; 2000 Dec; 44(6):365-9. PubMed ID: 11332280 [TBL] [Abstract][Full Text] [Related]
11. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors. Grant KG; Krisky DM; Ataai MM; Glorioso JC Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174 [TBL] [Abstract][Full Text] [Related]
12. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922 [TBL] [Abstract][Full Text] [Related]
13. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector. Zhu J; Kang W; Wolfe JH; Fraser NW Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831 [TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus-mediated gene delivery to the rodent visual system. Spencer B; Agarwala S; Miskulin M; Smith M; Brandt CR Invest Ophthalmol Vis Sci; 2000 May; 41(6):1392-401. PubMed ID: 10798655 [TBL] [Abstract][Full Text] [Related]
15. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons. Müller L; Saydam O; Saeki Y; Heid I; Fraefel C J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700 [TBL] [Abstract][Full Text] [Related]
16. Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector. Lu B; Gupta S; Federoff H Hepatology; 1995 Mar; 21(3):752-9. PubMed ID: 7875674 [TBL] [Abstract][Full Text] [Related]
17. Immunological consequences of HSV-1-mediated gene transfer into the CNS. Wood MJ; Byrnes AP; Rabkin SD; Pfaff DW; Charlton HM Gene Ther; 1994; 1 Suppl 1():S82. PubMed ID: 8542428 [TBL] [Abstract][Full Text] [Related]